Application for bio-equivalent test doubled in May.

The number of application for the bio-equivalent test in May rose rapidly amid which bio-equivalent test shall be obligated to submit for any generic product registration from the 2nd half of this year but the price controls up to 80% out of the original drug could be no longer effected. As of May 15, about 40 applications were filed to KFDA.

Viewing that up to April this year an average mo...